Beruflich Dokumente
Kultur Dokumente
Original Article
T
Abstract he atopic diseases like allergic rhino
Background Atopic diseases are determined by the interaction FRQMXQFWLYLWLVDVWKPDDQGDWRSLFGHUPDWLWLV
between genetic and environmental factors. The possible effects are the most common chronic diseases of
RILPPXQL]DWLRQDVRQHRIHQYLURQPHQWDOIDFWRUVRQDWRS\UHPDLQ
childhood and the prevalence is still
a matter of controversy.
Objective :HFRQGXFWHGDQREVHUYDWLRQDOFOLQLFDOHSLGHPLRORJ\ increasing.3 ,Q GHYHORSLQJ FRXQWULHV DVWKPD ZDV
to find out the protective effect of high vaccination coverage to considered to be low but recent studies have shown
atopy in children. that the prevalence is increasing especially in urban
Methods'XULQJ-DQXDU\WKURXJK0DUFKRIFKLOGUHQ compared to rural areas.4 Asthma and other atopic
DW*DUXGD3DGDVXNDDQG%DEDNDQ6DUL3ULPDU\+HDOWK&DUHLQ
Bandung were randomized from group with and without family
diseases were determined by the interaction between
history of atopic disease. Atopy derived from skin prick test and genetic and environmental factors. Family history is
total serum IgE was evaluated. Atopy was defined as a positive an important risk factor for atopy.4-6 Many other risk
skin test to any of the eight allergens tested. The immunizations factors for the development of atopic disease have
were recorded from Kartu Menuju Sehat .066WDWLVWLFDODQDO\VHV
EHHQLGHQWLILHG such as infection. Bacterial and viral
LQFOXGHG&KLVTXDUHWRFRPSDUHSUHYDOHQFHLQGHSHQGHQW7WHVW
DQG0DQQ:KLWQH\WRFRPSDUHPHDQ LQIHFWLRQVLQGXFHD7KSDWWHUQRIF\WRNLQHUHOHDVH
Results$WRS\ZDVIRXQGLQRIVXEMHFWVRIZKLFK SRWHQWLDOO\ VXSSUHVVLQJ WKH 7K LPPXQH UHVSRQVH
ZLWKDQGZLWKRXWDIDPLO\KLVWRU\RIDWRSLFGLVHDVH7KH involved in IgE mediated allergy and inhibited the
median of total serum IgE level was higher in children with family development of atopy.
history of atopic disease and in atopy children. Children were
JURXSHGDFFRUGLQJWRWRWDOGRVHRIEDVLFLPPXQL]DWLRQVDQG
,QWKHILUVW\HDURI OLIHWKHFKLOGUHQVLPPXQH
EDVHGRQProgram Pengembangan Imunisasi 33,7KHUHZDV system is relatively immature. This immaturity creates
nonsignificant association between total doses of immunization
DQGDWRS\(YHQWKRXJKQRVWDWLVWLFDOO\VLJQLILFDQWWKHFXPXODWLYH
immunization doses were inversely related to the median of total
serum IgE level.
Conclusions The immunization coverage has not decreased atopy
risk.[Paediatr Indones. 2008;48:358-63]. )URP 'HSDUWPHQW RI &KLOG +HDOWK 0HGLFDO 6FKRRO 3DGMDGMDUDQ
8QLYHUVLW\+DVDQ6DGLNLQ*HQHUDO+RVSLWDO%DQGXQJ,QGRQHVLD
Keywords: atopy, immunization, total serum IgE, Request reprint to ,VDEHOOD 5LDQGDQL 0' 'HSDUWPHQW RI &KLOG
family history of atopic disease +HDOWK0HGLFDO6FKRRO3DGMDGMDUDQ8QLYHUVLW\+DVDQ6DGLNLQ*HQHUDO
+RVSLWDO-O3DVWHXU1R%DQGXQJ,QGRQHVLD7HO
)D[
The subject characteristics based on family history greater on atopy children and significantly different
of atopic disease was seen in Table 1. There were no 3H[FHSWIRUJURXSZLWKIDPLO\KLVWRU\RIDWRSLF
statistical differences between groups with or without GLVHDVH3
KLVWRU\RIDWRSLFGLVHDVH7KHUHIRUHWKHVXEMHFWVZHUH
homogen. Table 3. The association between total serum ige level and
atopy
Table 1. Characteristic of children based on family history of P
atopic disease Total serum IgE on Atopy Nonatopy
value
History of atopic disease (+)
Family history of atopic disease
Characteristic P value N 44 92
0.317
(+)
Median 162.8 125.8
Sex Range 18.28-1,517 12.12->2,500
Boys 64 (45.1%) 66 (46.5%) 0.812 *KUVQT[QHCVQRKEFKUGCUG
Girls 78 (54.9%) 76 (53.5%) N 34 101
0.015*
Age (mo) Median 196.8 94.3
X (SB) 36.4 (1.8) 36.2 (1.8) 0.233 Range 16.08->2,500 5.22-1,459
All of Subjects
Range 32.1 40.5 32.5 40.2
N 78 193
Nutritional status 0.011*
Median 181.8 106.5
underweight 32 (22.5%) 39 (27.5%)
0.995 Range 16.08->2,500 5.22->2,500
well nourished 107 (75.4%) 101 (71.1%)
overweight 3 (2.1%) 2 (1.4%) Note: *P<0.05
Table 5. Total serum ige level on immunization coverage that even often appear before any clinical symptoms
Immunization Coverage P have developed.
Total serum IgE on
0-17 value The median of IgE level was also higher on
History of atopic disease (+)
atopy than nonatopy children and the difference was
N 42 94
Median 150.35 123.30
0.320 statistically significance except on group with family
Range 15.83->2,500 12.12-2,482 history of atopic disease. A child with atopy indicates
D7KSUHGRPLQDQFHWKDWSURGXFHV,J(DQWLERGLHVLQ
,Q WKLV VWXG\ ZH IRXQG WKDW WKH KLJKHU WKH response to ordinary exposures to allergens and
FXPXODWLYH GRVHV RI LPPXQL]DWLRQ WKH ORZHU WKH the term atopy can not be used until IgE sensitization
PHGLDQ RI WRWDO VHUXP ,J( EXW VWDWLVWLFDOO\ QR has been documented by a positive skin prick test.
VLJQLILFDQW3! The different kinetic in the development of IgE
antibodies in atopic and nonatopic children is well
known because excessive IgE antibody formation is a
Discussion hallmark of the atopic individual.
7KHLPPXQL]DWLRQUHFRUGVVKRZHGRQO\
Family history is an important risk factor for atopic children had completed basic immunization. There
disease. Subjects with a family history of atopic disease was no difference of atopy between groups that had
have a two- to threefold higher risk to develop atopic completed and uncompleted basic immunization (OR:
disease than those with no such history.4-6 &, 3 $QGHUVRQ ZKR
,QWKLVVWXG\WKHSUHYDOHQFHRIDWRS\RQJURXS used ecologic analysis to find the relation between the
ZLWK IDPLO\ KLVWRU\ RI DWRSLF GLVHDVH ZDV prevalence of symptoms of atopic diseases in children
FRPSDUHGWRRQJURXSZLWKRXW%M|UNVWpQFLWHG and immunization records at the national and local
E\ .RQLQJ found that if a child has one atopic ,6$$& FHQWUH OHYHOV IRU '37 %&* DQG PHDVOHV
SDUHQWWKHULVNWREHFRPHDOOHUJLFLVDSSUR[LPDWHO\ found no association with national immunization
LQFUHDVLQJ WR ZLWK WZR DWRSLF SDUHQWV rates to atopic disease in children. On the other
whereas without atopic parents the risk is around VLGH*UXEHUZKRDQDO\VHGWKHSUHYDOHQFHRIDWRSLF
Alford6 IRXQG DWRS\ FKLOGUHQ LI WKH\ GLVHDVHLQUHODWLRQWRLPPXQL]DWLRQFRYHUDJHIRXQG
KDG DQ DWRSLF PRWKHU DQG DWRS\ FKLOGUHQ LI the cumulative vaccine dose was inversely related to
WKHLUIDWKHUKDGDWRSLFGLVHDVHZKHUHDVZLWKRXWDWRSLF atopic dermatitis and asthma prevalences.18
SDUHQWV WKH SUHYDOHQFH RI DWRS\ ZDV 6 In this Our study showed no association between
VWXG\WKHIDPLO\KLVWRU\RIDWRSLFGLVHDVHEDVHGRQO\ immunization and atopy as atopy could be caused
on anamnesis without other examinations such as skin by multifactor and immunization is only one of the
SULFNWHVWRUVHUXPDOOHUJHQVSHFLILF,J(PLJKWFDXVH environmental factors. The limited information
a nonsignificant different of atopy between children regarding life style factors could lead to confounding
with or without family history of atopic disease. bias. A conscious choice of parents not to have their
The median of total serum IgE was higher than child immunized might go with other lifestyle factors
QRUPDO YDOXH IURP SDFNDJH LQVHUW UHDJHQW that effect the development of atopy.
,8P/,8P/,QDGGLWLRQWRDJHDQGJHQHWLF The mechanism contributing to microbial
IDFWRUVWKHWRWDOVHUXP,J(ZDVLQIOXHQFHGE\UDFLDO SURWHFWLRQ DJDLQVW DWRS\ UHODWHV WR GHQGULWLF FHOOV
IDFWRU2UJDOZKRVWXGLHG)LOLSLQRDQGZKLWH DQ HIILFLHQW $3& WKDW FDQ VWLPXODWH QDLYH 7 FHOOV
children born and raised in the United States found DQG GULYH WKHP WR 7K RU 7K :KHQ VWLPXODWHG
that in Filipino children the mean IgE level were dendritic cells can produce cytokines that may down-
significantly higher than in white children. The regulated allergic responses. The limited induction of
IgE level was higher on group with as compared to Th1 responses after immunization early in life appears
group without family history of atopic disease but the WRUHVXOWIURPVXERSWLPDOLQWHUDFWLRQVEHWZHHQ$3&
difference was not statistically significant. It was likely and T cells in infancy. The induction of adult-like Th1
because children with family history of atopic disease responses early in life requires optimal activation of
had a familial tendency to produce IgE antibodies neonatal dendritic cells.
3DXQLR 0 +HLQRQHQ 23 9LUWDQHQ 0 /HLQLNNL 3 3DWMD %M|UNVWpQ%7KHLQWUDXWHULQHDQGSRVWQDWDOHQYLURQPHQWV
$3HOWROD+0HDVOHVKLVWRU\DQGDWRSLFGLVHDVHV-$0$ -$OOHUJ\&OLQ,PPXQRO
-RKDQVVRQ 6*2 %LHEHU 7 'DKO 5 )ULHGPDQQ 36 /DQLHU
+XUZLW] (/ 0RUJHQVWHUQ + (IIHFWV RI 'LSKWKHULD %4/RFNH\5)et al. Revised nomenclature for allergy for
7HWDQXV3HUWXVVLV RU 7HWDQXV YDFFLQDWLRQ RQ DOOHUJLHV DQG global use: report of the nomenclature review committee of
allergy-related respiratory symptoms among children and WKHZRUOGDOOHUJ\RUJDQL]DWLRQ2FWREHU-$OOHUJ\&OLQ
DGROHVFHQWV LQ WKH 8QLWHG 6WDWHV - 0DQLSXODWLYH 3K\VLRO ,PPXQRO
7KHU %HOWUDQL96%RJXQHLZLF]0$WRSLFGHUPDWLWLV'HUPDWRORJ\
.RQLQJ + %DHUW 050 2UDQMH $3 6DYHONRXO +)- 1HLMHQV 2QOLQH -RXUQDO $YDLODEOH IURP KWWSZZZ
+- 'HYHORSPHQW RI LPPXQH IXQFWLRQV UHODWHG WR DOOHUJLF PHGVFDSHFRPYLHZDUWLFOH.
PHFKDQLVPLQ\RXQJFKLOGUHQ,Q.RQLQJ+HGLWRU7DQG%FHOO .RSSHQ6GH*URRW51HLMHQV+-1DJHONHUNH1YDQ(GHQ:
DFWLYDWLRQLQFKLOGKRRGDOOHUJ\5RWWHUGDPS 5PNH+&1RHSLGHPLRORJLFDOHYLGHQFHIRULQIDQWYDFFLQDWLRQV
<XQJLQJHU-:&OLQLFDOVLJQLILFDQFHRI,J(,Q0LGGOHWRQ WRFDXVHDOOHUJLFGLVHDVH9DFFLQH
(5HHG&((OOLV()$GNLQVRQ1)<XQJLQJHU-:HGLWRUV 8PHWVX '7 $NEDUL 2 'H.UX\II 5+ 5HJXODWRU\ 7 FHOOV
Allergy: principles and practice. 3th ed. Toronto: CV Mosby FRQWUROWKHGHYHORSPHQWRIDOOHUJLFGLDVHDVHDQGDVWKPD-
&RPSDQ\S $OOHUJ\&OLQ,PPXQRO